Clever Leaves (the “Company”), a leading
multi-national operator and licensed producer of
pharmaceutical-grade cannabinoids, announced today that its
Colombian operations have been named a Project of National and
Strategic Interests (“PINE”) by the Government of Colombia. The
PINE designation highlights the Colombian government’s continued
support of Clever Leaves’ work within the industry, as well as the
importance of its economic contributions to Colombia and the
growing medical cannabis industry. The PINE designation will offer
Clever Leaves accelerated and simplified administrative processes
as the Company continues to develop new products and services and
bring them to market.
Clever Leaves has worked closely with the
Colombian government since inception to commercialize and export
high-quality Colombian cannabis, as well as finished and
semi-finished medical cannabis products, with a focus on
operational sustainability and high production standards. Clever
Leaves has received multiple international quality certifications
that have enabled it to increase its export capabilities from
Colombia, including the first and only Good Manufacturing Practices
(GMP) Certification by INVIMA to a cannabis company; Good
Agricultural and Collecting Practices (GACP) Certification; and the
only European Union Good Manufacturing Practices (EU GMP)
Certification for a cannabis company in LATAM.
"The PINE designation is a reflection of our
continued efforts to work in partnership with the Colombian
government and recognition of the significant contributions to the
country’s medical cannabis industry and broader economy. We pride
ourselves on creating a business that not only generates a positive
return on investment but demonstrates operational sustainability
and positively impacts the community in which we operate,” said
Kyle Detwiler, CEO of Clever Leaves. “We anticipate the PINE
declaration to help streamline processes and coordination with
government entities as we work to commercialize Colombian medical
cannabis products and respond to evolving industry needs.”
“We appreciate the Colombian government’s
identification of Clever Leaves as a leader within the Colombian
industry and their support to bring EU-GMP certified cannabis
products to patients both domestically and internationally. With
this additional government commitment supporting efficient and
optimized processes and procedures, Clever Leaves continues to
establish Colombia as an epicenter for medical cannabis production,
while ensuring that the industry continues to create a significant
economic impact on an international and regional level,” said
Andrés Fajardo, President of Clever Leaves.
For all business inquiries, please visit Clever
Leaves’ direct to business sales platform, www.cleverleaves360.com,
to set up an appointment with a Clever Leaves’ business
consultant.
Clever Leaves was also recently in the news when
they announced a potential business combination with Schultze
Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU)
(“SAMA”) and disclosed the signing of a definitive agreement on
July 27th. The transaction is expected to close in the fourth
quarter of 2020 and the combined company is anticipated to trade on
the NASDAQ under the symbol “CLVR".
About Clever Leaves
International Inc.Clever Leaves is a multi-national
cannabinoid company with a mission to operate in compliance with
federal and state laws and with an emphasis on ecologically
sustainable, large-scale cultivation and pharmaceutical-grade
processing as the cornerstones of its global cannabinoid business.
With operations and investments in Canada, Colombia, Germany,
Portugal, and the United States, Clever Leaves has created an
effective distribution network and global footprint, with a
foundation built upon capital efficiency and rapid growth. Clever
Leaves aims to be one of the industry’s leading global cannabinoid
companies recognized for its principles, people, and performance
while fostering a healthier global community.
About Schultze Special Purpose Acquisition
Corp.Schultze Special Purpose Acquisition Corp. (NASDAQ:
SAMA, SAMAW, and SAMAU) is a blank check company formed for the
purpose of entering into a merger, stock exchange, asset
acquisition, stock purchase, recapitalization, reorganization or
other similar business combination with one or more businesses or
entities. SAMA’s sponsor is an affiliate of Schultze Asset
Management, LP, an alternative investment management firm founded
in 1998 that focuses on distressed, special situation and
event-driven securities and has invested over $3.2 billion since
inception with a notable track-record through its active investment
strategy. SAMA itself is backed by an experienced team of
operators and investors with a successful track-record of creating
material value in public and private companies.
Additional Information and Where to Find
ItIn connection with the Business Combination, Clever
Leaves Holdings Inc. (“Holdco”) has filed a Registration Statement
on Form S-4 (the “Form S-4”) with the SEC which includes a
prospectus with respect to Holdco’s securities to be issued in
connection with the Business Combination and a proxy statement with
respect to SAMA’s stockholder meeting at which SAMA’s stockholders
will be asked to vote on the proposed Business Combination. SAMA,
Clever Leaves and Holdco urge investors, stockholders and other
interested persons to read the Form S-4, including the proxy
statement/prospectus, as well as other documents filed with the
SEC, because these documents will contain important information
about the Business Combination. The definitive proxy
statement/prospectus will be mailed to stockholders of SAMA as of a
record date to be established for voting on the Business
Combination. SAMA’s stockholders will also be able to obtain a copy
of such documents, without charge, by directing a request to:
Schultze Special Purpose Acquisition Corp, 800 Westchester Avenue,
Suite 632, Rye Brook, New York 10573; e-mail: sdu@samco.net. These
documents, once available, can also be obtained, without charge, at
the SEC’s web site (http://www.sec.gov).
Participants in
SolicitationSAMA, Clever Leaves, Holdco and their
respective directors, executive officers and other members of their
management and employees, under SEC rules, may be deemed to be
participants in the solicitation of proxies of SAMA stockholders in
connection with the Business Combination. Information regarding the
persons who may, under SEC rules, be deemed participants in the
solicitation of proxies to SAMA’s stockholders in connection with
the Business Combination is set forth in the preliminary proxy
statement/prospectus contained in the Form S-4, and will also be
included in the definitive proxy statement/prospectus for the
Business Combination when available. Information concerning the
interests of SAMA’s and Clever Leaves’ participants in the
solicitation, which may, in some cases, be different than those of
SAMA’s and Clever Leaves’ equity holders generally, is also set
forth in the proxy statement/prospectus contained in the Form S-4,
and will also be included in the definitive proxy
statement/prospectus for the Business Combination when
available.
Forward Looking StatementsThis
press release includes forward-looking statements that involve
risks and uncertainties. Forward-looking statements are statements
that are not historical facts and may be identified by the words
"estimates," "projected," "expects," "anticipates," "forecasts,"
"plans," "intends," "believes," "seeks," "may," "will," "should,"
"future," "propose" and variations of these words or similar
expressions (or the negative versions of such words or
expressions). Such forward-looking statements are subject to risks
and uncertainties, which could cause actual results to differ from
the forward-looking statements. Factors that may cause such
differences include, without limitation, SAMA’s and Clever Leaves’
inability to complete the Business Combination; matters discovered
by the parties as they complete their respective due diligence
investigation of the other; the inability to recognize the
anticipated benefits of the Business Combination, which may be
affected by, among other things, the amount of cash available
following any redemptions by SAMA stockholders; the ability to meet
NASDAQ's listing standards following the consummation of the
Business Combination; costs related to the Business Combination;
expectations with respect to future operating and financial
performance and growth, including when Clever Leaves or Holdco will
become cash flow positive; the timing of the completion of the
Business Combination; Clever Leaves’ ability to execute its
business plans and strategy and to receive regulatory approvals;
potential litigation involving the parties; global economic
conditions; geopolitical events, natural disasters, acts of God and
pandemics, including, but not limited to, the economic and
operational disruptions and other effects of COVID-19; regulatory
requirements and changes thereto; access to additional financing;
and other risks and uncertainties indicated from time to time in
filings with the SEC. Other factors include the possibility that
the proposed transaction does not close, including due to the
failure to receive required security holder approvals, the failure
to obtain an extension of the business combination deadline if
sought by SAMA or the failure to satisfy other closing conditions.
The foregoing list of factors is not exclusive. Additional
information concerning certain of these and other risk factors is
contained in the Form S-4, including the proxy
statement/prospectus. All subsequent written and oral
forward-looking statements concerning SAMA, Clever Leaves or
Holdco, the transactions described herein or other matters and
attributable to SAMA, Clever Leaves, Holdco or any person acting on
their behalf are expressly qualified in their entirety by the
cautionary statements above. Readers are cautioned not to place
undue reliance upon any forward-looking statements, which speak
only as of the date made. Each of SAMA, Clever Leaves and Holdco
expressly disclaims any obligations or undertaking to release
publicly any updates or revisions to any forward-looking statements
contained herein to reflect any change in their expectations with
respect thereto or any change in events, conditions or
circumstances on which any statement is based.
Press contacts:McKenna Miller KCSA
Strategic
Communications +1347-487-6197mmiller@kcsa.com
Diana SigüenzaStrategic Communications
Director+573102368830Diana.siguenza@cleverleaves.com
Investor inquiries: Raphael
GrossICR+1203-682-8253raphael.gross@icrinc.com
Schultze Special Purpose... (NASDAQ:SAMAW)
Historical Stock Chart
From Sep 2024 to Oct 2024
Schultze Special Purpose... (NASDAQ:SAMAW)
Historical Stock Chart
From Oct 2023 to Oct 2024